PSEN1 and Alzheimer disease: In AD patients, CSF concentrations of Aβ1-43 were significantly reduced in FAD mutation carriers, mimicking the reduction in Aβ 42 seen in AD, and underlining a potential role of Aβ 43 in AD [28, 29].